Evidence map›Paper›PMID 11705944›Full record

ArticleInfection and immunity2001

Phase variation among major surface antigens of Mycoplasma penetrans.

K Röske, A Blanchard, I Chambaud, C Citti, J H Helbig, M C Prevost, R Rosengarten, E Jacobs

Abstract read
In one paragraph

Article in Infection and immunity, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Screening the receptors forFrontiers in cellular and infection microbiology · 2025
    Article
  2. A Review ofFrontiers in veterinary science · 2021
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Binding of IgA by Mycoplasma penetrans.Current microbiology · 2009
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Phase and antigenic variation in bacteria.Clinical microbiology reviews · 2004
    Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

K RöskeInstitut für Medizinische Mikrobiologie und Hygiene, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, D-01307 Dresden, Germany.
A Blanchard
I Chambaud
C Citti
J H Helbig
M C Prevost
R Rosengarten
E Jacobs

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pathogenicity and prevalence of Mycoplasma penetrans, a Mycoplasma species recently isolated from humans, are still debated. A major P35 antigen, which is used as target epitope in serological assays, was shown to be a phase-variable lipid-associated membrane protein (LAMP). In this study, we performed a comparative analysis of the LAMP patterns from five M. penetrans clinical isolates and from the type strain. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis profiles and immunoblots with sera serially collected from an M. penetrans-infected patient indicated that these strains expressed different LAMP repertoires. Furthermore, the intraclonal variation in the expression of LAMPs (P34A, P34B, P35, and P38) was monitored by immunoblot analysis with three specific monoclonal antibodies (MAbs) developed in this study and MAb 7 to P35. The phase variation of these LAMPs occurs in an independent manner, with frequencies of variation ranging from 10(-2) to 10(-4) per cell per generation. Consistent with their amphipathic nature, the P34B and P38 antigens were found exposed at the cell surface. The DNA sequence encoding the P38 antigen was defined and found to be related to those of the P35 gene and other putative LAMP-encoding genes, suggesting that these variable antigens are encoded by a family of related genes. Finally, the serum samples from an M. penetrans-infected patient contained antibodies that reacted with a P36 antigen expressed in different M. penetrans strains but not in the isolate recovered from this patient. This result suggested that in vivo phase variation of P36 occurred, which would support a role for these LAMP variations in avoiding the host's immune vigilance.

Indexed as

Antigenic VariationAmino Acid SequenceAntibodies, BacterialAntibodies, MonoclonalAntigens, BacterialAntigens, SurfaceBacterial Typing TechniquesHumansMolecular Sequence DataMycoplasma InfectionsMycoplasma penetransRandom Amplified Polymorphic DNA TechniqueSequence AnalysisSequence Homology, Amino AcidSpecies SpecificityAntibodies, BacterialAntibodies, MonoclonalAntigens, BacterialAntigens, SurfaceP34B antigen, MycoplasmaP38 antigen, Mycoplasma

Identifiers

PMID11705944
PMCPMC98858

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.